Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Inclusion Criteria: * 18 to 40 years of age * Male≥50 kg, female≥45 kg with 18.5≤ BMI ≤30 * Subject has provided informed consent Exclusion Criteria: * Subject has respiratory diseases, circulatory system diseases, digestive system diseases, urinary system diseases, hematological system diseases, autoimmune diseases, endocrine disorders or metabolic disorders; * Subject has nervous system diseases, mental illness, Creutzfeldt-Jakob disease or those with a family history, or those treated with tissue or tissue derivatives that may be derived from Creutzfeldt-Jakob infected people; * Subject has chronic skin diseases, especially infectious, allergic or inflammatory systemic skin diseases; * Subject has allergic diseases or recurrent allergies; * Malignant tumors or health-affecting benign tumors; * Twice or more times of blood pressure measurement exhibit (except for white coat hypertension): systolic blood pressure \< 90 or ≥ 140 Millimeter of mercury (mm Hg), or diastolic blood pressure \< 60 or ≥ 90 mm Hg, or pulse pressure \< 30 mm Hg, heart rate: \< 60 beats/min or \>100 beats/min; * Laboratory tests: hemoglobin: male \<120 g/L, female \<115 g/L, or liver and kidney laboratory result \>1.5x upper limit of normal with clinical significant, or abnormal12-lead ECG with clinical significant, or abnormal abdominal B-mode ultrasound with clinical significant, or abnormal chest X-ray with clinical significant, and T cell detection of tuberculosis infection is over the limit or positive; * Abnormal lymphocyte subset panel test result with clinical significance (Lymphs%, CD3+, CD3+CD4+, CD3+CD8+, CD3-CD16+CD56+,CD19+) ; * Hepatitis B surface antigen positive, hepatitis B virus (HBV) DNA positive, hepatitis B e antigen positive, hepatitis C antibody positive, Treponema pallidum antibody positive ,human immunodeficiency virus antibody positive, human T-cell lymphotrophic virus antibody positive, Epstein-Barr virus positive, or COVID-19 nucleic acid positive ; * Recipient of organ transplant; * Received any major organ resection such as stomach, kidney, spleen and lung; * Subject has transfusion-associated infectious diseases; * Minor surgery within 3 months, such as appendectomy and recovered ophthalmic surgery; Major surgery within l 1 year, such as surgical treatment for gynecological benign tumors or superficial benign tumors; * Pregnant, or have an abortion within l 6 months, childbirth within 1 year; * Upper respiratory infection recovered within 1 week, or pneumonia recovered within 3 months; * Acute pyelonephritis-recovered within 3 months, or urinary calculi onset; * Injured or wound-contaminated by equipment contaminated by blood or tissue fluids, or has a tattoo within 1 year; * Received whole blood and blood component transfusion within 1 year; * Received the last vaccination of live attenuated vaccines such as measles, mumps, or polio within 2 weeks, or the last vaccination of rubella live vaccine, human rabies vaccine, live attenuated Japanese encephalitis vaccine within 4 weeks; * Received the last vaccination of rabies vaccines after being bitten by an animal within 1 year; * Received the last vaccination of antitoxin or immune serum injection within 4 weeks, or those who received the last vaccination of hepatitis B human immunoglobulin injection within 1 year; * Participated in a clinical trials within 1 month; it should be discussed case by base if investigational product used. * Those who are considered by the investigator as unsuitable for participating in the study.